Microfluidics for research and applications in oncology.

Analyst

Mechanobiology Institute, National University of Singapore, Singapore 117411 and BioSystems and Micromechanics (BioSyM) IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre, Singapore 138602.

Published: January 2016

Cancer is currently one of the top non-communicable human diseases, and continual research and developmental efforts are being made to better understand and manage this disease. More recently, with the improved understanding in cancer biology as well as the advancements made in microtechnology and rapid prototyping, microfluidics is increasingly being explored and even validated for use in the detection, diagnosis and treatment of cancer. With inherent advantages such as small sample volume, high sensitivity and fast processing time, microfluidics is well-positioned to serve as a promising platform for applications in oncology. In this review, we look at the recent advances in the use of microfluidics, from basic research such as understanding cancer cell phenotypes as well as metastatic behaviors to applications such as the detection, diagnosis, prognosis and drug screening. We then conclude with a future outlook on this promising technology.

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5an00382bDOI Listing

Publication Analysis

Top Keywords

applications oncology
8
understanding cancer
8
detection diagnosis
8
microfluidics
4
microfluidics applications
4
cancer
4
oncology cancer
4
cancer currently
4
currently top
4
top non-communicable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!